Earlier this week, China Pharma Holdings told investors to expect a better-than 60% increase in its Q1 revenues and net income (year over year). Not surprisingly, the company made good on its promise. Revenue was up 62% at $11.7 million, gross profits climbed 76% to $5.8 million, and net income rose 77% to $4.2 million. Earnings per share were 72% higher at 11 cps. Although the report was generally positive, one item was giving investors pause.  More details...

Stock Symbol: (OTCBB: CPHI)